Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

Area of Science:

• Biochemistry
• Cell Biology
• Critical Care Medicine

Background:

• Multiorgan dysfunction syndrome (MODS) is a leading cause of death in intensive care units (ICUs).
• The underlying mechanisms of MODS remain poorly understood, with no specific cure available beyond life support.
• Catalytic iron accumulation is implicated in ICU mortality, contributing to cellular toxicity via free radical-mediated pathways.

Purpose of the Study:

• To investigate the association between plasma catalytic iron, lipid peroxidation, and MODS severity and mortality.
• To explore the role of ferroptosis, an iron-dependent cell death pathway, in the pathogenesis of iron-induced MODS.
• To evaluate the therapeutic potential of inhibiting lipid peroxidation in experimental MODS models.

Main Methods:

• Correlation analysis of plasma catalytic iron and lipid peroxidation levels with MODS severity and mortality.
• Utilizing transgenic mouse models to elucidate the role of ferroptosis in iron-induced MODS.
• Administering a ferrostatin-analogue to block lipid peroxidation in experimental non-septic and sepsis-induced MODS models.

Main Results:

• Plasma catalytic iron and lipid peroxidation levels were significantly associated with MODS severity and mortality.
• Transgenic studies confirmed ferroptosis's involvement in iron-induced multiorgan dysfunction.
• Ferrostatin-analogue treatment protected against injury and mortality in non-septic MODS but not in sepsis-induced MODS.
• Experimental mouse models have limitations in fully replicating clinical MODS complexity.

Conclusions:

• Ferroptosis is a key mechanism in iron-induced MODS.
• Targeting ferroptosis represents a potential therapeutic strategy for a specific patient subgroup within MODS.
• Further preclinical research is necessary to validate these findings for clinical application.